Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Senate Dems Plan To Force Budget Vote On Medicare Rx Price Negotiating By HHS

This article was originally published in The Pink Sheet Daily

Executive Summary

Non-binding amendment would reference expected savings from negotiating for single-source drugs with no competition. Sen. Wyden had sought clarification on the issue from the Congressional Budget Office.

You may also be interested in...

Employer Options For Retiree Health Plans Outlined In Proposed Medicare Drug Rule

CMS is declining to predict whether the four retiree health coverage options available to employers and outlined in a Medicare proposed rule issued July 26 will be sufficient to stem the tide of employer dropouts

Diminished Drug R&D Could Be Price Of Closing Medicare "Donut Hole"

Price setting or negotiations could allow for seamless Medicare Rx coverage without overall cost increase, according to an analysis by Johns Hopkins' Anderson; trade-off of 45% price reduction would be limited research and development.

Medicare Rx Card Firms May Be Violating Pharmacy Access Mandate – Rep. Waxman

Sponsors' use of pharmacy passive acceptance agreements could be contributing to inaccurate participation data on Medicare Web site, House Democrats say. AdvancePCS, Anthem and Medco among firms in question.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts